Fitgurú on MSN
Could popular weight-loss drugs increase the risk of vision loss? New study raises concerns
Researchers analyzing U.S. safety reports say certain medications containing semaglutide may be linked to a rare eye ...
Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?
Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but at the expense of higher side effect rates.
Irish Examiner on MSN
Wegovy users have five times greater risk of sudden sight loss than Ozempic users - study
'Eye strokes' cause sudden and usually permanent vision loss due to reduced blood flow to the optic nerve ...
Feb 26 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill, orforglipron, caused more side effects and treatment discontinuations than Novo Nordisk's (NOVOb.CO), opens new tab ...
People with type 2 diabetes had better blood sugar control and more weight loss with orforglipron than with oral semaglutide (Rybelsus) — but also more side effects. For people with type 2 diabetes, ...
April 2 (Reuters) - (To receive the full newsletter in your inbox for free sign up here) Novo Nordisk’s (NOVOb.CO), opens new tab diabetes medicine Rybelsus, an oral form of the GLP-1 drug semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results